News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Novo Nordisk A/S (NVO) and Paula Deen Offer Chance to Experience Paula's Approach to Healthier Living

3/8/2013 9:06:54 AM

PRINCETON, N.J., March 7, 2013 /PRNewswire/ -- Novo Nordisk, in partnership with American cooking star Paula Deen, is giving those with type 2 diabetes, and their loved ones, a chance to walk in Paula's footsteps this year beginning with the launch of the Seeing Diabetes in a New Light® contest and continuing through a variety of diabetes-focused awareness activities. Paula has made a number of changes to improve her health since announcing her own diagnosis last year and is now sharing these efforts to encourage others to make the same commitment.

To view the multimedia assets associated with this release, please click:


"I've seen a positive impact from making small changes with my overall health and in managing my diabetes, y'all," said Paula. "I'm a big believer that sharing your story about healthier living can really help inspire and educate others, and motivate your own journey at the same time. That's what this coming year and the Seeing Diabetes in a New Light® contest mean to me. We want to inspire people because together, we can make a difference."

This contest, which runs through April 14, 2013, was created to inspire others by asking adults with type 2 diabetes, or their loved ones, to share stories about the positive changes they have made to manage their disease. Six winners and their guests will be invited to Paula's hometown of Savannah, Ga., for a unique experience, as they join her in some of the activities she participates in daily to manage her diabetes. These activities include having a cozy diabetes-friendly lunch with Paula and her son Bobby at The Lady & Sons, taking a guided walking tour of Savannah, and attending an educational diabetes conference hosted by Taking Control of Your Diabetes.

Entries can be submitted through the Diabetes in a New Light®website at All qualified entrants will receive a Delicious Living Y'all e-recipe guide, featuring tips to manage type 2 diabetes as well as diabetes-friendly recipes created by Paula and her sons Bobby and Jamie, in conjunction with certified diabetes professionals.

To further support the diabetes community, Novo Nordisk will make a donation of $5.00 for every qualified entry received, up to $50,000, to key diabetes organizations, including Taking Control of Your Diabetes, the American Diabetes Association, and Diabetes Care and Education, a practice group of the Academy of Nutrition and Dietetics. In addition, Paula will share her personal experiences in managing the disease during several diabetes awareness events taking place across the country.

"As the world leader in diabetes care, Novo Nordisk is committed to our patients and to helping them be in control of their lives and their health," said Camille Lee, corporate senior vice president, Diabetes Marketing at Novo Nordisk. "We look forward to hearing how they, like Paula, are seeing diabetes 'in a new light' and are pleased to be supporting the diabetes community along the way."

Official Rules for submission are available by visiting

About Diabetes in a New Light®
The Diabetes in a New Light®initiative, which features Paula Deen along with her sons, Bobby and Jamie, provides resources and information to help adults tackle common challenges associated with diabetes management. Visit the campaign website,, for tips and resources.

About Type 2 Diabetes
In the United States alone, nearly 26 million people are affected by diabetes. Type 2 diabetes accounts for 90 to 95 percent of all diabetes cases. Diabetes is emerging as one of the most serious health problems of our time; the number of Americans with diabetes has tripled over the last 30 years.

Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy, and hormone replacement therapy. For more information, visit

SOURCE Novo Nordisk

Read at

comments powered by Disqus